|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Cash flows from operating activities | |||
| Loss for the year | |||
| Adjustments for: | |||
| - Tax expense/(credit) | |||
| - Employee share grant and option expense | |||
| Non-executive director share grant and option expense | |||
| - Amortisation and depreciation | |||
| - Impairment of intangible assets | |||
| - Impairment of plant, equipment and right-of-use assets | |||
| - Loss on disposal of plant and equipment and intangible assets | |||
| - Gain on lease modification | |||
| - Interest income | |||
| - Finance cost | |||
| - (Reversal of impairment)/Impairment loss on financial assets | |||
| - Unrealised currency translation losses | |||
| - Fair value loss/(gain) of Series B, D1, E and F conversion option | |||
| - Fair value gain on warrant liabilities | |||
| - Fair value loss on contingent consideration | |||
| - Fair value gain on convertible notes option | |||
| - Share listing expense | |||
| Adjustments to reconcile profit (loss) other than changes in working capital | |||
| Change in working capital, net of effects from acquisition and disposal of subsidiaries | |||
| - Trade and other receivables | |||
| - Trade and other payables | |||
| - Deferred revenue | |||
| Cash (used in)/provided by operations | |||
| Interest received | |||
| Income tax paid | |||
| Net cash (used in)/provided by operating activities | |||
| Cash flows from investing activities | |||
| Additions to plant and equipment | |||
| Additions of intangible assets | |||
| Acquisition of subsidiaries, net of cash acquired | |||
| Payment of contingent consideration from acquisition of business | |||
| Payment of contingent consideration from acquisition of subsidiary | |||
| Proceeds from disposal of plant and equipment | |||
| Net cash used in investing activities | |||
| Cash flows from financing activities | |||
| Interest paid | |||
| Proceeds from loan advance | |||
| Proceeds from borrowings | |||
| Proceeds from term loan | |||
| Repayments of borrowings | |||
| Borrowings transaction cost | |||
| Principal payment of lease liabilities | |||
| Proceeds from Reorganisation | |||
| Proceeds from the shares issued to PIPE investors | |||
| Transaction cost in relation to issuance of PIPE shares | |||
| Proceeds from issuance of preference shares | |||
| Proceeds from issuance of ordinary shares | |||
| Payment for legal and professional fees incurred for IPO | |||
| Repayment of convertible notes | |||
| Net cash provided by/(used in) financing activities | |||
| Net increase/(decrease) in cash and cash equivalents | |||
| Cash and cash equivalents | |||
| Beginning of financial year | |||
| Effects of currency translation on cash and cash equivalents | |||
| End of financial year |
Loading...
